Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4289)
All Articles published online
|
Jun 7, 2008 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Silveira MG, Lindor KD. Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3338-3349 [PMID: 18528931 DOI: 10.3748/wjg.14.3338] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i21/3338.htm |
| Number | Citing Articles |
| 1 |
A Zampetti, E Rinninella, R Manna, F Franceschi. Scleroderma and liver disease: a case of an association with primary sclerosing cholangitis. Scandinavian Journal of Rheumatology 2016; 45(4): 334 doi: 10.3109/03009742.2015.1114667
|
| 2 |
Roger W. Chapman, Kate D. Williamson. Crohn's Disease and Ulcerative Colitis. 2017; : 531 doi: 10.1007/978-3-319-33703-6_52
|
| 3 |
Maria Teresa A. Seville, Roberto L. Patron, Ann McCullough, Shimon Kusne. Practical Gastroenterology and Hepatology Board Review Toolkit. 2016; : 487 doi: 10.1002/9781119127437.ch78
|
| 4 |
R. Vialle, S. Velasco, S. Milin, J.-P. Richer, V. Bricot, P.-M. Levillain, J.-P. Tasu. Imagerie des tumeurs bénignes des voies biliaires et de la vésicule. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2008; 3(4): 1 doi: 10.1016/S1879-8527(08)72832-6
|
| 5 |
Howard C. Masuoka, Raj Vuppalanchi, Ross Deppe, Phelan Bybee, Megan Comerford, Suthat Liangpunsakul, Marwan Ghabril, Naga Chalasani. Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis. Digestive Diseases and Sciences 2015; 60(12): 3642 doi: 10.1007/s10620-015-3805-7
|
| 6 |
Gian Andrea Rollandi, Riccardo Piccazzo, Francesco Paparo. Crohn’s Disease. 2016; : 127 doi: 10.1007/978-3-319-23066-5_14
|
| 7 |
Annika Gauss, Peter Sauer, Adolf Stiehl, Christian Rupp, Johannes Krisam, Yvonne Leopold, Petra Kloeters-Plachky, Wolfgang Stremmel, Daniel Gotthardt. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis. Medicine 2016; 95(17): e3510 doi: 10.1097/MD.0000000000003510
|
| 8 |
Erin W. Thackeray, William Sanchez. Practical Gastroenterology and Hepatology: Liver and Biliary Disease. 2010; : 383 doi: 10.1002/9781444325249.ch36
|
| 9 |
Wiebke‐Felicitas Nierath, Emily Leitner, Sabrina Reimann, Rico Schwarz, Burkhard Hinz, André Bleich, Brigitte Vollmar, Dietmar Zechner. GSK805 inhibits alpha‐smooth muscle expression and modulates liver inflammation without impairing the well‐being of mice. The FASEB Journal 2024; 38(16) doi: 10.1096/fj.202400733R
|
| 10 |
Asher Kornbluth, David B Sachar. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee. American Journal of Gastroenterology 2010; 105(3): 501 doi: 10.1038/ajg.2009.727
|
| 11 |
Aksana Höblinger, Sven Jonas, Gereon Gäbelein, Tillmann Sauerbruch. Viszeralmedizin. 2015; : 351 doi: 10.1007/978-3-642-14301-4_24
|
| 12 |
Seth N Sclair, Ester Little, Cynthia Levy. Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clinical and Translational Gastroenterology 2015; 6(8): e109 doi: 10.1038/ctg.2015.33
|
| 13 |
Sridhar Sundaram, Vaneet Jearth. Primary Sclerosing Cholangitis: A Clinical Update. European Medical Journal 2019; : 101 doi: 10.33590/emj/10313809
|
| 14 |
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Seminars in Liver Disease 2021; 41(03): 409 doi: 10.1055/s-0041-1730950
|
| 15 |
Guillaume Pineton de Chambrun, Maria Nachury, Natalie Funakoshi, Romain Gerard, Michael Bismuth, Jean-Christophe Valats, Fabrizio Panaro, Francis Navarro, Pierre Desreumaux, Benjamin Pariente, Pierre Blanc. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1247 doi: 10.1097/MEG.0000000000001223
|
| 16 |
Marina G Silveira, Natalie J Torok, Andrea A Gossard, Jill C Keach, Roberta A Jorgensen, RN, Janice L Petz, RN, Keith D Lindor. Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study. The American Journal of Gastroenterology 2009; 104(1): 83 doi: 10.1038/ajg.2008.14
|
| 17 |
Peter Fickert, Andrea Thueringer, Tarek Moustafa, Dagmar Silbert, Judith Gumhold, Oleksiy Tsybrovskyy, Margitta Lebofsky, Hartmut Jaeschke, Helmut Denk, Michael Trauner. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Laboratory Investigation 2010; 90(6): 844 doi: 10.1038/labinvest.2010.61
|
| 18 |
S. Segato, I. Arena. An unusual association of rare diseases. Journal of Medicine and the Person 2010; 8(2): 78 doi: 10.1007/s12682-010-0048-4
|
| 19 |
Takahiro Tsuchikawa, Satoshi Kondo, Satoshi Hirano, Eiichi Tanaka, Kentaro Kato, Joe Matsumoto, Kanako C. Kubota, Toshiaki Shichinohe. Extensively spreading intraepithelial bile duct carcinoma causing multiple bile duct strictures: Report of three cases. Surgery Today 2011; 41(12): 1674 doi: 10.1007/s00595-011-4508-0
|
| 20 |
Emmanouil Sinakos, Hanns-Ulrich Marschall, Kris V. Kowdley, Alex Befeler, Jill Keach, Keith Lindor. Bile Acid Changes After High-Dose Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis: Relation to Disease Progression. Hepatology 2010; 52(1): 197 doi: 10.1002/hep.23631
|
| 21 |
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
|
| 22 |
Ian R. Mackay. Clustering and commonalities among autoimmune diseases. Journal of Autoimmunity 2009; 33(3-4): 170 doi: 10.1016/j.jaut.2009.09.006
|
| 23 |
Kidist K. Yimam, Christopher L. Bowlus. Diagnosis and classification of primary sclerosing cholangitis. Autoimmunity Reviews 2014; 13(4-5): 445 doi: 10.1016/j.autrev.2014.01.040
|
| 24 |
Andrea Tringali, Vincenzo Bove, Guido Costamagna. Endoscopic approach to benign biliary obstruction. Gastrointestinal Intervention 2015; 4(1): 1 doi: 10.1016/j.gii.2015.04.001
|
| 25 |
Emmanouil Sinakos, Sunil Samuel, Felicity Enders, Edward V. Loftus, William J. Sandborn, Keith D. Lindor. Inflammatory Bowel Disease in Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2013; 19(5): 1004 doi: 10.1097/MIB.0b013e3182802893
|
| 26 |
Josiah D. McCain, David M. Chascsa, Keith D. Lindor. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients. Expert Opinion on Orphan Drugs 2021; 9(2): 53 doi: 10.1080/21678707.2021.1898370
|
| 27 |
Werner Van Steenbergen, Lieve Braeye, Rudy Harlet, Frederik Nevens, Johan Fevery, Valeer Desmet, Tania Roskams, Jacques Pirenne. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. European Journal of Gastroenterology & Hepatology 2010; 22(10): 1265 doi: 10.1097/MEG.0b013e32833dbd81
|
| 28 |
Cyriac Abby Philips, Philip Augustine, Nikhil Phadke. Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis – A Single Case Report. Journal of Clinical and Translational Hepatology 2018; 6(xx): 1 doi: 10.14218/JCTH.2018.00033
|
| 29 |
Vincenzo Perri, Pietro Familiari, Andrea Tringali, Ivo Boskoski, Guido Costamagna. Plastic Biliary Stents for Benign Biliary Diseases. Gastrointestinal Endoscopy Clinics of North America 2011; 21(3): 405 doi: 10.1016/j.giec.2011.04.012
|
| 30 |
Hiroaki Sawai, Hiroyuki Matsubayashi, Keiko Sasaki, Masaki Tanaka, Naomi Kakushima, Kohei Takizawa, Yuichiro Yamaguchi, Hiroyuki Ono. A Case of Sclerosing Cholangitis without Pancreatic Involvement Thought to be Associated with Autoimmunity. Internal Medicine 2011; 50(5): 433 doi: 10.2169/internalmedicine.50.4471
|
| 31 |
|
| 32 |
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 2023; 15(20): 4947 doi: 10.3390/cancers15204947
|
| 33 |
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
|
| 34 |
Jocelyn Trottier, Andrzej Białek, Patrick Caron, Robert J. Straka, Jenny Heathcote, Piotr Milkiewicz, Olivier Barbier. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study. Digestive and Liver Disease 2012; 44(4): 303 doi: 10.1016/j.dld.2011.10.025
|
| 35 |
Kimchi Nguyen, Charlotte D’Mello, Tai Le, Stefan Urbanski, Mark G. Swain. Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice. Journal of Hepatology 2012; 56(3): 626 doi: 10.1016/j.jhep.2011.09.014
|
| 36 |
Amber G. Bozward, Vincenzo Ronca, Daniel Osei-Bordom, Ye Htun Oo. Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.711217
|
| 37 |
Vanja Giljaca, Goran Poropat, Davor Stimac, Christian Gluud. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database of Systematic Reviews 2010; doi: 10.1002/14651858.CD004036.pub3
|
| 38 |
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139
|
| 39 |
John Halliday, Roger W. Chapman. Crohn's Disease and Ulcerative Colitis. 2012; : 579 doi: 10.1007/978-1-4614-0998-4_47
|
| 40 |
Tim Fulmer. A TRAIL in liver disease. Science-Business eXchange 2008; 1(26): 615 doi: 10.1038/scibx.2008.615
|
| 41 |
Hiroyuki Matsubayashi, Kimihiro Igarashi, Yoshihiro Kishida, Yukio Yoshida, Keiko Sasaki, Hiroyuki Ono. Sclerosing cholangitis with thumbprint appearance and incomplete steroid response. Journal of Digestive Diseases 2014; 15(10): 578 doi: 10.1111/1751-2980.12176
|
| 42 |
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; : 52 doi: 10.1016/B978-1-4377-0765-6.10003-5
|
| 43 |
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
|
| 44 |
Maria Teresa A. Seville, Ann McCullough, Shimon Kusne. Practical Gastroenterology and Hepatology: Liver and Biliary Disease. 2010; : 200 doi: 10.1002/9781444325249.ch20
|